Intravenous Heparin for the Prevention of Stroke Progression in Acute Partial Stable Stroke.
Completed
Phase N/A ResultsSummary of Purpose
To evaluate the efficacy of intravenous heparin in the prevention of stroke progression or death in patients with acute partial stable stroke.
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 9 November 2000.
| Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Start Date | First Received | 1st Completion | Completion | Verification | Results |
|---|
Trial Basics
Interventions
Sponsors
- Canadian and Ontario Heart and Stroke Foundation, Hamilton Civic Hospitals Research Fund.
Trial Design
Randomized, double-blind, placebo-controlled trial of 225 patients at 3 centers.
Contacts
Not available
Recruitment
- Gender: Both
- Study Size: 225
- Number of Centers: 3
- Max Time from Onset: 48 Hours
- Follow Up: 1 Years
Principal Investigator
-
Robert J. Duke, M.D.
McMaster University Department of Medicine.
Locations
- Hamilton, Ontario; Toronto, Ontario